Advisor Group Holdings, Inc. Night Hawk Biosciences, Inc. Transaction History

Advisor Group Holdings, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$0.26 - $0.51 $100 - $196	-385 Reduced 79.38%	100 $0
Q3 2023 Nov 13, 2023	BUY	$0.5 - $0.72 $85 - $122	170 Added 53.97%	485 $0
Q1 2023 May 12, 2023	SELL	$0.83 - $1.24 $1,494 - $2,232	-1,800 Reduced 85.11%	315 $0
Q3 2022 Nov 14, 2022	SELL	$1.79 - $2.96 $25 - $41	-14 Reduced 0.66%	2,115 $3,000
Q2 2022 Aug 10, 2022	BUY	$1.65 - $3.13 $23 - $43	14 Added 0.66%	2,129 $6,000
Q1 2022 May 04, 2022	SELL	$2.1 - $3.54 $3,822 - $6,442	-1,820 Reduced 46.25%	2,115 $7,000
Q3 2021 Nov 05, 2021	BUY	$5.9 - $7.44 $4,248 - $5,356	720 Added 22.4%	3,935 $23,000
Q2 2021 Aug 02, 2021	BUY	$5.78 - $9.6 $17,340 - $28,800	3,000 Added 1395.35%	3,215 $21,000
Q4 2020 Feb 10, 2021	BUY	$5.28 - $9.59 $1,135 - $2,061	215 New	215 $1,000

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.